These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8747899)

  • 41. Rate constants of embolization and quantitation of emboli from the hollow-fiber oxygenator and arterial filter during cardiopulmonary bypass.
    Dewanjee MK; Palatianos GM; Kapadvanjwala M; Novak S; Hsu LC; Serafini AN; Sfakianakis GN
    ASAIO J; 1992; 38(3):M317-21. PubMed ID: 1457873
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Feasibility and rate of leucocyte depletion with a single leucocyte depletion filter during massive transfusion.
    Rieger A; Saefkow M; Hass I; Spies C; Eyrich K
    Infusionsther Transfusionsmed; 1995 Dec; 22(6):355-9. PubMed ID: 8589596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficiency and safety of leukocyte filtration during cardiopulmonary bypass for cardiac surgery.
    Smit JJ; de Vries AJ; Gu YJ; van Oeveren W
    Transfus Sci; 1999 Jun; 20(3):151-65. PubMed ID: 10623356
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ex vivo testing of the Quart arterial line filter.
    Mueller XM; Tevaearai HT; Jegger D; Augstburger M; Burki M; von Segesser LK
    Perfusion; 1999 Nov; 14(6):481-7. PubMed ID: 10585156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of four filters for leukocyte depletion of single donor plateletapheresis products.
    Sintnicolaas K; van Putten WL
    Transfus Sci; 1993 Apr; 14(2):211-5. PubMed ID: 10148614
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of plasma components by leukocyte removal filters.
    Gu YJ; Van Oeveren W
    ASAIO J; 1994; 40(3):M598-601. PubMed ID: 8555585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pulsatile compared with nonpulsatile perfusion using a centrifugal pump for cardiopulmonary bypass during coronary artery bypass grafting. Effects on systemic haemodynamics, oxygenation, and inflammatory response parameters.
    Driessen JJ; Dhaese H; Fransen G; Verrelst P; Rondelez L; Gevaert L; van Becelaere M; Schelstraete E
    Perfusion; 1995; 10(1):3-12. PubMed ID: 7795311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical effectiveness of leukocyte filtration during cardiopulmonary bypass in patients with chronic obstructive pulmonary disease.
    Karaiskos TE; Palatianos GM; Triantafillou CD; Kantidakis GH; Astras GM; Papadakis EG; Vassili MI
    Ann Thorac Surg; 2004 Oct; 78(4):1339-44. PubMed ID: 15464496
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of autologous blood as part of the perfusate for cardiopulmonary bypass: a priming technique.
    Myers GJ; Legare JF; Sullivan JA; Leadon RB; Johnstone R; Swyer W; Squires C; Power C; Hirsch GM
    Perfusion; 2002 May; 17(3):211-6. PubMed ID: 12017390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of the RemoweLL cardiotomy reservoir for fat and leucocyte removal from shed mediastinal blood: a randomized controlled trial.
    Lagny MG; Gothot A; Hans GA; Koch JN; Blaffart F; Hella D; Donneau AF; Roediger L; Lecut C; Pincemaïl J; Cheramy-Bien JP; Defraigne JO
    Perfusion; 2016 Oct; 31(7):544-51. PubMed ID: 27178989
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
    Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB
    ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurological and neuropsychological examination and outcome after use of an intra-aortic filter device during cardiac surgery.
    Eifert S; Reichenspurner H; Pfefferkorn T; Baur B; von Schlippenbach C; Mayer TE; Hamann G; Reichart B
    Perfusion; 2003 Mar; 18 Suppl 1():55-60. PubMed ID: 12708766
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Evaluation of the efficacy of a leukocyte depletion filter].
    Mitsuhata H; Togashi H; Hirabayashi Y; Horiguchi Y; Fukuda H; Saitoh K; Shimizu R
    Masui; 1993 Jan; 42(1):16-9. PubMed ID: 8433486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effects of leukocyte depletion filter on canine kidney during cardiopulmonary bypass].
    Yang YB; Zhu ZQ; Zheng H; Du L; Huang SM
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):321-4. PubMed ID: 16045024
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function. A clinical study.
    Mihaljevic T; Tönz M; von Segesser LK; Pasic M; Grob P; Fehr J; Seifert B; Turina M
    J Thorac Cardiovasc Surg; 1995 Jun; 109(6):1138-45. PubMed ID: 7776678
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Complement consumption during cardiopulmonary bypass: comparison of Duraflo II heparin-coated and uncoated circuits in fully heparinized patients.
    Hamulu A; Dişcigil B; Ozbaran M; Calkavur T; Kara E; Kokuludağ A; Büket S; Bilkay O
    Perfusion; 1996 Jul; 11(4):333-7. PubMed ID: 8884862
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of leucodepletion in patients who develop the systemic inflammatory response syndrome following cardiopulmonary bypass.
    Treacher DF; Sabbato M; Brown KA; Gant V
    Perfusion; 2001 Mar; 16 Suppl():67-73. PubMed ID: 11334210
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prebypass filtration of cardiopulmonary bypass circuits: an outdated technique?
    Merkle F; Böttcher W; Hetzer R
    Perfusion; 2003 Mar; 18 Suppl 1():81-8. PubMed ID: 12708770
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improved platelet compatiblity of water vapour glow discharge treated non-woven poly(ethylene terephthalate) leukocyte-reduction filters for different types of platelet concentrates.
    Kostelijk EH; Klomp AJ; Engbers GH; Gouwerok CW; Verhoeven AJ; van Aken WG; Feijen J; de Korte D
    Transfus Med; 2001 Jun; 11(3):199-205. PubMed ID: 11422950
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Use of cardiopulmonary bypass decreases leukocyte count and activation of the complement system].
    Bochenek A; Religa Z; Kokot F; Knapik P; Wnuk R; Komarski K; Wojnar J; Pietrzycki A; Skiba J
    Kardiol Pol; 1992; 36(2):67-72. PubMed ID: 1583828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.